6min chapter

Value Hive Podcast cover image

Shrubbery Capital Pt. 2: Process, Simplicity, & TikTok Investing

Value Hive Podcast

CHAPTER

Regeneron and Aylia - What's the Difference?

I was long regenerant at some point, which I think is a fantastic company. Their pharma business was a weak spot for them before Monsanto. They have a drug called Asudexium, which is the most promising drug in their pipeline. The companies in this is going to be buyer, Bristol Myers, Johnson & Johnson. And if they had been ex-litigation, this would have been a very valuable company.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode